• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Drug Products
  • All Drug Products
  • Comparative Efficacy & Safety Study of D961H Versus Placebo for the Prevention of Gastric and Duodenal Ulcers With Low-dose Aspirin

Disease
acid reflux
Drug Name
non drug study (gastrointestinal)
Generic Name
D961H
Sponsor
AstraZeneca
Drug Status
In Development
Phase
III
Start Date
Feb 1, 2010
Study Name
D961PC00001
Study Id
D961PC00001
ClinicalTrials.gov ID
NCT01069939
Recruiting Status
Closed
Protocol Status
Not Available
Report
Mar 5, 2012
  • D961PC00001.pdf (507 KB)

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013